Live feed12:36:00·71dPRReleasevia QuantisnowPureTech Announces Orphan Drug Designations Granted by the U.S. Food and Drug Administration and European Commission for Deupirfenidone (LYT-100) in Idiopathic Pulmonary FibrosisByQuantisnow·Wall Street's wire, on your screen.PRTC· PureTech Health plcHealth Care
